Deborah Cooper

A new USDA certification for biobased tableware promises clarity in a market flooded with vague claims. But does it solve the plastic problem?

A new partnership unites AI data-crunching with lab-grown human brain organoids, charting a bold roadmap to deconstruct Parkinson's into treatable subtypes.

Starting in 2028, a landmark federal mandate will force hospitals to track and treat malnutrition, a costly and dangerous condition affecting millions.

A new partnership aims to solve the security governance gap in hybrid clouds, shifting the focus from mere defense to intelligent policy control.

GrayMatters Health hires a top insurance exec to get its novel, AI-powered PTSD therapy covered. Can digital biomarkers finally break the reimbursement barrier?

As the educational child care leader marks a milestone, its focus on educator accreditation and major philanthropy reveals a modern strategy for building trust.

IDEAYA Biosciences advances its breakthrough melanoma drug toward FDA review while its $1.24B cash runway fuels a deep pipeline targeting cancer's toughest codes.

A new ultra-luxury development in LoHi promises ski simulators and sky pools, but its arrival highlights the widening gap in Denver's housing landscape.

The community bank's record-setting profitability and dividend hike signal strength, yet declining deposits and rising troubled loans tell a complex story.

TWC Enterprises reported lower Q2 earnings, but the real story isn't the 9% drop in golf rounds. It's the company's growing reliance on volatile real estate and stock market gains.

A major property sale in Pärnu falls apart, leaving Nordic Fibreboard with a strategic void. We explore the risks of 'conditions precedent' and what this means for the company.

A recall of a vital pet arthritis drug due to glass fibers reveals a history of quality control failures, forcing a difficult reckoning for pet owners and vets.

After devastating floods, Texans face a new wave of contractor fraud. Learn to spot the red flags and protect your finances during this vulnerable time.

A landmark ruling reverses a 20-year precedent, giving families of medical malpractice victims the time they need to grieve before seeking justice.

The community bank's Q2 profit turnaround isn't just a number—it's a blueprint for navigating a tough market through smart growth and pristine credit quality.

TekSynap's appointment of Brent Newman signals a critical shift: in an era of intense competition for cleared talent, human capital is the ultimate mission asset.

As Aristotle Funds launches its first ETFs, it bets on human expertise in a crowded market. A look at whether its 'relative-value' approach can stand out.

How one firm's million-hour safety milestone reveals a new competitive moat where operational excellence and risk management forge market dominance.

A critical bottleneck in the U.S. defense supply chain is getting a high-tech fix. Kratos' new partnership with Rangeview could redefine how we build next-gen drones and missiles.

Beyond the legacy hubs, a quiet industrial heartland is solving the Pentagon's biggest problem: building things. Here’s why Northeast Indiana matters.